[1]
Karki, B., Sherpa, T.W., Deo, R.K. and Thapa, P. 2024. Clinical response to Rifaximin amongst irritable bowel syndrome (IBS) patients at tertiary level hospital in Nepal. Journal of Patan Academy of Health Sciences. 11, 1 (Jun. 2024), 21–26. DOI:https://doi.org/10.3126/jpahs.v11i1.65652.